LFCR — Lifecore Biomedical Share News
0.000.00%
Last trade - 00:00- $242.60m
- $380.42m
- $128.87m
Lifecore Biomedical Inc reports results for the quarter ended February 28 - Earnings Summary
Brief: Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results
Lifecore Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Humanetics Selects Lifecore Biomedical To Deliver CDMO Services Supporting Development Of BIO 300 For The Prevention Of Acute Radiation Syndrome
U.S. RESEARCH ROUNDUP-Citigroup, Fortinet, Kenvue
Lifecore Biomedical Inc reports results for the quarter ended November 30 - Earnings Summary
Brief: Lifecore Biomedical Amends And Extends Revolving Credit Facility With BMO
U.S. RESEARCH ROUNDUP-Humana, Portillos, Waters
Brief: Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule
U.S. RESEARCH ROUNDUP- Autodesk, Elastic, GMS
Lifecore Biomedical Inc reports results for the quarter ended in May 31 - Earnings Summary
Brief: Lifecore Bio Announces Chief Financial Officer Transition
Lifecore Biomedical Inc expected to post a loss of 35 cents a share - Earnings Preview
Brief: Lifecore Biomedical Announces Cooperation Agreement With 22NW
Lifecore Biomedical Inc expected to post a loss of 26 cents a share - Earnings Preview
Lifecore Biomedical Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Lifecore Biomedical Got Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard Transfer Of Listing From Nasdaq
Lifecore Biomedical Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Lifecore Biomedical Inc Says Effective May 19 James Hall Resigned As A Co's Director, Ceases CEO Role